Effect of mibefradil, a T-type calcium channel blocker, on morbidity and mortality in moderate to severe congestive heart failure: the MACH-1 study. Mortality Assessment in Congestive Heart Failure Trial (Q34507289)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effect of mibefradil, a T-type calcium channel blocker, on morbidity and mortality in moderate to severe congestive heart failure: the MACH-1 study. Mortality Assessment in Congestive Heart Failure Trial |
scientific article |
Statements
1 reference
Effect of mibefradil, a T-type calcium channel blocker, on morbidity and mortality in moderate to severe congestive heart failure: the MACH-1 study. Mortality Assessment in Congestive Heart Failure Trial (English)
1 reference
Levine TB
1 reference
Bernink PJ
1 reference
Caspi A
1 reference
Elkayam U
1 reference
Geltman EM
1 reference
Greenberg B
1 reference
McKenna WJ
1 reference
Ghali JK
1 reference
Giles TD
1 reference
Marmor A
1 reference
Reisin LH
1 reference
Ammon S
1 reference
Lindberg E
1 reference
1 February 2000
1 reference
Identifiers
1 reference